CVS Caremark

CVS Settles with SEC Over Accounting Violations
Risk & Compliance

CVS Settles with SEC Over Accounting Violations

The enforcement action is another sign of increased scrutiny of corporate accounting by the Securities and Exchange Commission.
By Marielle Segarra | April 8, 2014
Read More
CVS Jettisons a Cash Cow
Strategy

CVS Jettisons a Cash Cow

The pharmacy chain isn't the first retailer to stop selling tobacco products, nor the first company to forgo a chunk of revenue.
By Marielle Segarra | February 7, 2014
Read More
Drug-Benefits War Heats Up
People

Drug-Benefits War Heats Up

Pharmacy benefits management goliath Express Scripts has a smaller but fattened-up competitor nipping at its heels. An interview with Jeff Park, CFO of new number-four player Catamaran.
By David McCann | July 23, 2012
Read More
Walgreen, Express Scripts End War
Human Capital & Careers

Walgreen, Express Scripts End War

The pharmacy chain blinks first in the parties' epic pricing struggle — perhaps setting the stage for corporate cost savings on drug benefits.
By David McCann | July 19, 2012
Read More
Ahold CFO Dances as Fast as She Can
People

Ahold CFO Dances as Fast as She Can

The speedy pace and razor-thin margins of the retail industry energize finance chief Paula Price.
By David McCann | July 13, 2012
Read More
Five Costly Health-Care Compliance Slips
Risk Management

Five Costly Health-Care Compliance Slips

Small companies may be especially prone to these potential oversights &spamp;#8212; and may pay a price if they&spamp;rsquo;re unlucky enough to get audited.
By David McCann | March 14, 2012
Read More
Companies May Win This Drug War
Human Capital & Careers

Companies May Win This Drug War

The conflict between Express Scripts and Walgreen just might lead to lower drug-benefit costs for companies.
By David McCann | March 1, 2012
Read More
Walgreen-Express Scripts War Could Cut Drug Costs
Human Capital & Careers

Walgreen-Express Scripts War Could Cut Drug Costs

The pricing donnybrook between the giant chain and the big pharmacy benefits manager could give plan sponsors more market clout.
By David McCann | January 18, 2012
Read More